drugset / Trial / NCT00090584

Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

NCT00090584

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.

Timeline

Start
2004-08
Primary completion
2005-12
Completion
2006-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolterodine Small molecule 4 mg